ALLMedicine™ Bacterial Pneumonia Center

Jan 17th, 2022 - Bactericidal antibiotics are generally assumed to be superior to bacteriostatic antibiotics as first-line treatment for pneumonia. We performed a systematic review, meta-analysis, and trial sequential analysis (TSA) of randomized controlled trials...

Jan 14th, 2022 - Pneumonia is the most common serious infection in childhood. In the United States (US), pneumonia accounts for 1-4% of all emergency department (ED) visits in children (3-28 per 1,000 US children per year) and ranks among the top 3 reasons for ped...

Jan 14th, 2022 - Coronavirus disease-2019 (COVID-19) is associated with a wide spectrum of clinical symptoms including acute respiratory failure. Biomarkers that can predict outcomes in patients with COVID-19 can assist with patient management. The aim of this stu...

Jan 8th, 2022 - Inappropriate antibiotics use in lower respiratory tract infections (LRTI) is a major contributor to resistance. We aimed to design an algorithm based on clinical signs and host biomarkers to identify bacterial community-acquired pneumonia (CAP) a...

Jan 5th, 2022 - A 71-year-old woman previously on rituximab treatment for rheumatoid arthritis presented with 2 years of progressive neurologic symptoms. She was found to have persistent hypogammaglobulinemia and B cell depletion despite rituximab discontinuation...

Jan 14th, 2022 - Pneumonia is the most common serious infection in childhood. In the United States (US), pneumonia accounts for 1-4% of all emergency department (ED) visits in children (3-28 per 1,000 US children per year) and ranks among the top 3 reasons for ped...

Jan 3rd, 2022 - This study will evaluate the efficacy and safety of imipenem/cilastatin/relebactam (IMI/REL) (MK-7655A) compared to piperacillin/tazobactam (PIP/TAZ) in the treatment of adults diagnosed with Hospital-Acquired Bacterial Pneumonia (HABP) or Ventila...

Nov 3rd, 2021 - The purpose of this study is to evaluate the pharmacokinetics of an oral omadacycline dosing regimen in the treatment of adults with CABP.

Nov 3rd, 2021 - The need for MAC prophylaxis in advanced HIV disease is recognized. Prophylactic therapy is complicated, however, due to drug toxicity, potential drug interactions, patient noncompliance with multiagent regimens, microbial drug resistance, and hig...

Sep 24th, 2021 - Pneumonia is one of the most common health conditions leading to hospitalization today. Approximately 1.3 million people in the US are admitted to the hospital with community-acquired pneumonia (CAP) annually, with readmission rates within the fir...

Jan 2nd, 2022 - [[{"fid":"282102","view_mode":"medstat_image_flush_left","fields":{"format":"medstat_image_flush_left","field_file_image_caption[und][0][value]":"","field_file_image_caption[und][0][format]":"filtered_html","field_file_image_credit[und][0][value]".

Dec 8th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. COVID-19 patients with severe disease were significantly less likely to require mechanical ventilation when treated with high-flow oxygen therapy ...

Sep 13th, 2021 - Takeaway The annual incidence of bacterial pneumonia treated at a secondary care centre in the UK fell by more than a third in 2020, when the COVID-19 pandemic began. The decline could be potentially attributed to reduced transmission of bacterial...

Aug 24th, 2021 - NEW YORK (Reuters Health) - Community treatment with doxycycline did not reduce time to recovery or rates of hospital admission or death in patients with suspected COVID-19 who were at high risk of adverse outcomes, according to randomized trial f...

Apr 30th, 2021 - This transcript has been edited for clarity. Christopher J. Chiu, MD: Welcome back to The Cribsiders on Medscape. We are the pediatric medicine podcast, and on these videos we recap our interviews with leading experts in the field to bring you cli...